Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol (GWP42003-P) Pilot in Infantile Spasms
NCT02953548Phase 3Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Apr 2017
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of cannabidiol in infantile epileptic spasms syndrome (IESS), sponsored by Jazz Pharmaceuticals plc. Started Apr 2017; status: completed.
02
Drugs
cannabidiol
03
Conditions
infantile epileptic spasms syndrome (IESS)
Beyond the preview
Go deeper on NCT02953548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02953548.